Clinical Trial Update: the Effect of Vitamin D on the Serum Thioredoxin, TBP-2, Thioredoxin Reductase, Gene Expression of TBP-2 in Patients With Type II Diabetes [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update evaluating the effect of Vitamin D (cholecalciferol) on serum thioredoxin, TBP-2, thioredoxin reductase, and TBP-2 gene …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Cholecalciferol (Vitamin D3) (cholecalciferol)

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Type 2 Diabetes | Phase 4 | Status: UNKNOWN